Summary • Lexaria Bioscience Corp. (LEXX) shares fell 9.1% to $0.5633 despite recent successful clinical study results.• The company reported a significant reduction in side effects from its Phase 1b ...
Summary • Bone Biologics Corporation (BBLG) shares fell 10.1% to $1.75 amid investor selling pressure.• The company announced a manufacturing milestone, extending the shelf life of its rhNELL-1 ...
Summary • SRx Health Solutions Inc. shares rose 16.5% to $0.2561 amid investor interest, despite the absence of a clear catalyst for the price increase.• The company expanded its risk-intelligence ...
Summary • Reviva Pharmaceuticals shares dropped 15% to $0.2732 during intraday trading amid regulatory updates.• The FDA advised Reviva to conduct a second Phase 3 trial for brilaroxazine before NDA ...
Summary • Can-Fite BioPharma shares fell 19.9% to $0.1926 following a reverse stock split announcement.• The company will implement a 1-for-3,000 reverse split effective January 2, 2026, approved by ...
Summary • Vor Biopharma Inc. (VOR) shares increased by 10.9% to $15.01 following new board appointments.• The company announced a $150 million PIPE financing, enhancing growth and strategic leadership ...
Summary • Edgewise Therapeutics’ stock (EWTX) rose 15.6% to $25.13 amid positive clinical trial news.• Completion of Phase 2 trials for EDG-7500 and favorable safety results enhance investor sentiment ...
Summary • Wearable Devices Ltd. (WLDS) saw a 7.3% increase in stock price during intraday trading, reaching $1.47.• A partnership with Rokid aims to integrate gesture control technology into AR ...
Our proprietary market analysis suggests predictions for Icon Energy 's price over the next three months point to a drop. ICON stock is expected to peak at $2.93 on Jan 19, 2026 before potentially ...
Summary • ICZOOM Group Inc. (IZM) shares rose 11% in pre-market trading, reaching $1.99 from a previous close of $1.80.• An extraordinary general meeting of shareholders is scheduled for February 27, ...
Summary • Cemtrex Inc. (CETX) declines 6% in pre-market trading, priced at $2.31, following a $2 million direct offering announcement.• The company plans to sell approximately 800,000 shares at $2.50 ...
Summary • VivoPower International PLC (VVPR) shares declined 7% in pre-market trading, down to $2.22 from $2.38.• The drop follows a strategic refocus on “Power-to-X,” aiming to enhance AI compute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback